Publication:
Management of fibular Hemimelia using the Ilizarov method at Siriraj hospital in Thailand

dc.contributor.authorPrangthong Unpraserten_US
dc.contributor.authorKamolporn Kaewpornsawanen_US
dc.contributor.authorChatupon Chotigavanichayaen_US
dc.contributor.authorPerajit Eamsobhanaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-11-09T02:43:14Z
dc.date.available2018-11-09T02:43:14Z
dc.date.issued2014-01-01en_US
dc.description.abstract© 2014, Medical Association of Thailand. All Rights Reserved. Background: Fibular hemimelia is one of the most common congenital longitudinal bone deficiencies. Previous treatment protocols called for amputation of the deficient limb; while others made attempts to save the limb. The objective of treatment is to restore function and achieve patient satisfaction. The authors evaluated the outcomes of the Ilizarov technique for the treatment of leg-length discrepancy and bone associated deformities in patients with fibular hemimelia. The present study also evaluated and assessed complications, knee and ankle function, and patient satisfaction with the treatment. Material and Method: Nine patients with fibular hemimelia who underwent tibial lengthening using the Ilizarov method were reviewed in the present study. Initial condition data, including age, gender, type of fibular hemimelia, initial limb-length discrepancy, predicted limb-length discrepancy, and the data were collected and analyzed. Activity level, patient satisfaction, complications, and residual leg-length discrepancy were assessed at the end of treatment. Results: According to Achterman and Kalamchi classification, there were 4 patients with Type IA, 3 patients with Type IB, and 2 patients with Type II. In Type IA, the affected leg-length discrepancy and mean age at the initial treatment were 3.25 cm and 7.75 years, respectively. In type IB, the affected leg-length discrepancy and mean age at the initial treatment were 5.83 cm and 4.3 years, respectively. In Type II, the affected leg-length discrepancy and mean age at the initial treatment were 5.5 cm and 5 years, respectively. The mean follow-up was 5 years (range: 7-10). The mean lengthening was 7.52 cm (range: 4-13). The lengthening index was 1.28 mo/cm. The mean residual leg-length discrepancy was 0.94 cm. There was ankle joint stiffness and mild equinous foot in type II cases, but patients could walk well without gait aid. No patients were experiencing pain by the end of treatment. All patients expressed satisfaction with this technique. Conclusion: The Ilizarov technique for bone lengthening of the tibia has shown satisfactory results in the treatment of all types of congenital fibular hemimelia and should be considered an attractive alternative to amputation, as measureable functional improvement can be expected.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.97, (2014), S44-S49en_US
dc.identifier.issn01252208en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-84922212884en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34364
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922212884&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleManagement of fibular Hemimelia using the Ilizarov method at Siriraj hospital in Thailanden_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922212884&origin=inwarden_US

Files

Collections